Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Two cases of lumbosacral myeloradiculitis with anti-aquaporin-4 antibody.
New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come.
The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica.
MS as a gateway disease.
Chaperone activity of small heat shock proteins underlies therapeutic efficacy in experimental autoimmune encephalomyelitis.
NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG.
Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: A 7 Tesla MRI study.
Melatonin Acts as Antioxidant and Improves Sleep in MS Patients.
Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?
Heterogeneity of cortical lesions in multiple sclerosis: Clinical and pathologic implications.
White Matter MS-Lesion Segmentation Using a Geometric Brain Model.
Something Old, New, Borrowed, Blue: Anthracenedione Agents for Treatment of Multiple Sclerosis.
Biotherapeutics for the treatment of multiple sclerosis: hopes and hazards.
Update in pediatric optic neuritis.
Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis.
Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis.
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response.
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencing.
Botulinum Toxin Injection Techniques for Management of Adult Spasticity.
MRI relaxation in the presence of fictitious fields correlates with myelin content in normal rat brain.
Intracortical Posterior Cingulate Myelin Content Relates to Error Processing: Results from T1- and T2-Weighted MRI Myelin Mapping and Electrophysiology in Healthy Adults.
Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
If I had clinically isolated syndrome with magnetic resonance imaging diagnostic of multiple sclerosis, I would take vitamin D 10,000 IU daily: Yes.
Vitamin A: yet another player in multiple sclerosis pathogenesis?
Pages
« first
‹ previous
…
455
456
457
458
459
460
461
462
463
…
next ›
last »